Deliverable reports

Del. noDeliverable nameWP No.Lead
Beneficiary
NatureDiss.
Level [1]
Delivery date
Document
1.1Establishment of General Assembly, Management Office, and Working Groups1LUMCReportCO01/10/2015Delivered
1.4Kick-off Meeting1LUMCReportCO01/12/2015Delivered
1.2Project Website1LUMCWebsites etc.PU01/03/2016www.bridges-research.eu
2.1Gene selection panel 12CNIOReportCO01/03/2016Delivered
4.1mCherry-cDNA constructs for 11 BC-HR genes4LUMCDemonstratorCO01/09/2016Delivered
2.4Gene selection Panel 22CNIOReportCO01/03/2017
2.2Sequencing results Panel 12UCAMReportCO01/09/2017
2.3Sensitivity of Panel 12LUReportCO01/09/2017
4.2A catalogue of naturally occurring alternative splicing4SERMASDemonstratorPU01/09/2017
4.3A high-throughput functional analysis system (RIgORouS)4LUMCDemonstratorPU01/09/2017
4.4VUSPlot4LUMCDemonstratorCO01/09/2017
4.527 3DM Models4LUMCDemonstratorCO01/09/2017
5.1Survey results of BOADICEA5ICReportPU01/09/2017
5.2Validated instruments for the identification of patients with psychological distress5IC DemonstratorPU01/09/2017
1.5Midterm Meeting1LUMCReportCO01/09/2018
2.5Sequencing results Panel 22UCAMReportCO01/09/2018
2.6Sensitivity of Panel 22UCAMReportCO01/09/2018
3.1Risk estimates Panel 13UCAMReportPU01/09/2018
3.2Combined analysis of exome and gene panel sequencing3UCAMReportPU01/09/2018
4.6A panel of validated minigene-based splicing assays4CSICDemonstratorPU01/09/2018
5.3An e-Learning tool for genetic counsellors5UKKOELNDemonstratorPU01/09/2018
5.4Patient decision aid for counselees5UKKOELNDemonstratorPU01/09/2018
5.5A template for psychological intervention5ICReportPU01/09/2018
2.7Gene selection BRIDGES Panel2CNIOReportCO01/03/2019
4.7250 mCherry-cDNA constructs with VUS4LUMCDemonstratorCO01/09/2019
2.8Sequencing results BRIDGES Panel2UCAMReportCO01/03/2020
3.3Risk estimates Panel 23UCAMReportPU01/03/2020
3.4Report on BOADICEA-PLUS3UCAMReportPU01/03/2020
3.5Upgraded Alamut Tool3IBSWebsites etc.PU01/03/2020
3.6Risk model validation3UCAMReportPU01/03/2020
4.8Results from RIgORouS analysis4LUMCReportPU01/03/2020
4.9A catalogue of (non-)spliceogenic variants4SERMASReportPU01/03/2020
1.3Dissemination of variants1LUMCWebsites etc.PU01/09/2020
1.6Final Meeting1LUMCReportPU01/09/2020
3.7Predictive value of functional analyses3UCAMReportPU01/09/2020
5.6Position report on best practice and recommendations for genetic counselling5UKKOELNReportPU01/09/2020
5.7Survey results of BOADICEA-PLUS5ICReportPU01/09/2020
6.1POPD - Requirement No.96LUMCEthicsCO01/09/2018
6.2POPD - Requirement No,66LUMCEthicsCO01/09/2018Delivered
6.3HCT - Requirement No.36LUMCEthicsCO01/09/2018
LUMC= Leiden Unicersity Medical Centre, CNIO= Fundación Centro Nacional De Investigaciones Oncológicas Carlos III, LU= Lunds Universitet, IC= Institut Curie, SERMAS= Servicio Madrileno de Salud, UCAM= The Chancellor, Masters and Scholars of the University of Cambridge, and IBS= Interactive Biosoftware

 

[1] PU = Public, PP = Restricted to other programme participants (including the Commission Services). RE = Restricted to a group specified by the consortium (including the Commission Services). CO = Confidential, only for members of the consortium (including the Commission Services).